Pages that link to "Q40544847"
Jump to navigation
Jump to search
The following pages link to Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging (Q40544847):
Displaying 50 items.
- Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease (Q24633911) (← links)
- Nutritional Cognitive Neuroscience: Innovations for Healthy Brain Aging (Q26745425) (← links)
- Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals (Q26995405) (← links)
- Insights into the ageing mind: a view from cognitive neuroscience (Q28239895) (← links)
- Prediction of cognitive decline in healthy older adults using fMRI (Q28383378) (← links)
- Provenance in neuroimaging (Q28754875) (← links)
- The developing utility of zebrafish models for cognitive enhancers research (Q30457705) (← links)
- ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice (Q30539979) (← links)
- Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease (Q30597321) (← links)
- Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques (Q30765803) (← links)
- Structural imaging measures of brain aging (Q30844186) (← links)
- Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease (Q30988163) (← links)
- Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression (Q31042195) (← links)
- Longitudinal imaging in dementia. (Q31153983) (← links)
- APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging (Q33423191) (← links)
- Associations between total cerebral blood flow and age related changes of the brain (Q33547465) (← links)
- Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition (Q33559175) (← links)
- Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies (Q33590723) (← links)
- Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. (Q33652639) (← links)
- Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease (Q33731565) (← links)
- Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function (Q33862397) (← links)
- Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal (Q33862533) (← links)
- Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes (Q33863423) (← links)
- Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia (Q33887766) (← links)
- Trajectories of brain aging in middle-aged and older adults: regional and individual differences (Q33889612) (← links)
- Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease (Q33947426) (← links)
- Structural imaging in early pre-states of dementia (Q33967561) (← links)
- Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies (Q34019300) (← links)
- Mild Cognitive Impairment: Baseline and Longitudinal Structural MR Imaging Measures Improve Predictive Prognosis (Q34176310) (← links)
- Probing the biology of Alzheimer's disease in mice (Q34206962) (← links)
- The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging (Q34296479) (← links)
- Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease (Q34436072) (← links)
- Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume? (Q34520736) (← links)
- Early indications of future cognitive decline: stable versus declining controls (Q34989712) (← links)
- Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism (Q35055317) (← links)
- Hippocampal atrophy varies by neuropsychologically defined MCI among men in their 50s (Q35133348) (← links)
- Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders (Q35231675) (← links)
- Mild cognitive impairment: historical development and summary of research (Q35236843) (← links)
- Adaptation of brain functional and structural networks in aging (Q35433363) (← links)
- Positron emission tomography scans obtained for the evaluation of cognitive dysfunction (Q35446894) (← links)
- Age effects on atrophy rates of entorhinal cortex and hippocampus (Q35606365) (← links)
- Spectrum of neurocognitive dysfunction in Indian population on FDG PET/CT imaging (Q35610981) (← links)
- Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus (Q35677152) (← links)
- Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease (Q35772524) (← links)
- Information-Theoretic Characterization of Blood Panel Predictors for Brain Atrophy and Cognitive Decline in the Elderly (Q36081690) (← links)
- Brain aging: reorganizing discoveries about the aging mind (Q36098588) (← links)
- Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment (Q36163298) (← links)
- Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson's disease: a longitudinal analysis (Q36182681) (← links)
- Neuroprotective and cognitive-enhancing effects of the combined extract of Cyperus rotundus and Zingiber officinale (Q36295791) (← links)
- Biological markers of age-related memory deficits: treatment of senescent physiology (Q36396408) (← links)